Financial reports
ARS
2023 FY
Annual report to shareholders
5 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
1 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
6 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Regulation FD Disclosure
24 Apr 24
8-K
Other Events
7 Mar 24
8-K
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress
26 Feb 24
8-K
Day One Announces Two New Appointments to Board of Directors
17 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
8 Dec 23
8-K
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine
17 Nov 23
8-K
Changes in Registrant's Certifying Accountant
15 Nov 23
8-K
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress
6 Nov 23
8-K
Regulation FD Disclosure
30 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
4 Jan 24
S-3ASR
Automatic shelf registration
14 Sep 23
424B5
Prospectus supplement for primary offering
7 Jun 23
424B5
Prospectus supplement for primary offering
6 Jun 23
S-8
Registration of securities for employees
13 Feb 23
S-8
Registration of securities for employees
31 Oct 22
424B5
Prospectus supplement for primary offering
16 Jun 22
424B5
Prospectus supplement for primary offering
14 Jun 22
S-3
Shelf registration
1 Jun 22
S-8
Registration of securities for employees
7 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
5 Apr 24
DEF 14A
Definitive proxy
5 Apr 24
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
Other
EFFECT
Notice of effectiveness
14 Jun 22
CORRESP
Correspondence with SEC
8 Jun 22
UPLOAD
Letter from SEC
3 Jun 22
EFFECT
Notice of effectiveness
27 May 21
CERT
Certification of approval for exchange listing
26 May 21
SEC STAFF
SEC staff action: Order
26 May 21
CORRESP
Correspondence with SEC
24 May 21
CORRESP
Correspondence with SEC
24 May 21
CORRESP
Correspondence with SEC
24 May 21
SEC STAFF
SEC staff action: Order
18 May 21
Ownership
4
Samuel C. Blackman
22 Apr 24
4
Samuel C. Blackman
26 Mar 24
4
Samuel C. Blackman
13 Mar 24
4
Samuel C. Blackman
28 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
4
Adam Dubow
20 Feb 24
4
Charles N York II
20 Feb 24
4
Samuel C. Blackman
20 Feb 24
4
Jeremy Bender
20 Feb 24
144
Notice of proposed sale of securities
16 Feb 24